Baxter (BAX) Cash Flow Statement

Click line-items for a historical chart and %

Cash flows from operations
Net income
Adjustments
Depreciation and amortization	599M
Deferred income taxes
Stock compensation	84M
Realized excess tax benefits from stock issued under employee benefit plans	-36M
Infusion pump charge
Other	236M
Changes in balance sheet items
Accounts and other current receivables	22M
Inventories	-11M
Accounts payable and accrued liabilities
Infusion pump and business optimization payments
Other, including pension contributions
Cash flows from operations	941M
Cash flows from investing activities
Capital expenditures	-519M
Acquisitions and investments	-47M
Divestiture and other
Cash flows from investing activities	-536M
Cash flows from financing activities
Issuances of debt	1.64B
Payments of obligations	-1.38B
Cash dividends on common stock	-197M
Proceeds and realized excess tax benefits from stock issued under employee benefit plans	286M
Purchases of treasury stock	-45M
Other	-30M
Cash flows from financing activities	-44M
Effect of currency exchange rate changes on cash and equivalents	23M
Decrease in cash and equivalents	384M
Cash and equivalents at beginning of period	2.21B
Cash and equivalents at end of period	2.6B

Entities mentioned with BAX